Trial Profile
Addition of H. P Acthar Gel to Treatment Regimen of Patients With Rheumatoid Arthritis Inadequately Controlled With Biologic Disease-Modifying Antirheumatic Drugs
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 13 Jun 2015 Interim results (n=6) presented at the 16th Annual Congress of the European League Against Rheumatism.
- 07 May 2015 New trial record